Benzalkonium Chloride for Antimicrobial Control in Pharmaceuticals

Innovation in formulations doesn’t always require new ingredients; sometimes it’s about rethinking how to utilize already proven components. By harnessing the established capabilities of benzalkonium chloride (BKC), formulators can develop improved pharmaceutical products that address contemporary challenges while enhancing patient experience.

BKC has a strong history of efficacy as an antimicrobial agent, widely utilized in ophthalmic, nasal and topical pharmaceutical formulations. As a powerful antimicrobial surfactant, BKC’s reliability is well documented. It demonstrates significant efficacy against a broad spectrum of microorganisms, even at very low concentrations. This allows formulators to deliver potent and safe solutions while minimizing irritation and enhancing patient comfort.

BKC is unique for its versatility and stability, easily integrating into various product formats, including creams, gels and solutions. Its dual functionality as both an active ingredient and a preservative not only helps fight infections but also contributes to product stability and shelf life — critical factors in multi-dose products. As formulators continually seek to innovate within competitive markets, this adaptability positions BKC as an asset.

Furthermore, ongoing research indicates that incorporating BKC into acne treatments can improve the combat of antibiotic-resistant and biofilm-forming microorganisms. At minimal irritation, it demonstrates potential for modern therapeutic solutions.

Transform the approach to antimicrobial ingredients and improve product formulations. The featured speakers in this webinar will dive deeper into the advantages of pharmaceutical-grade BKC and share their latest antimicrobial effectiveness testing results for acne and ophthalmic formulations. Discover how this time-tested ingredient can elevate formulation development, support innovation strategies and help deliver superior outcomes that prioritize both efficacy and safety.

Register for this webinar to learn how BKC can enhance formulation stability and antimicrobial performance in pharmaceutical products.

Speaker

Chantale Julien, Global Product Manager, Novo Nordisk Pharmatech A/S

With over 20 years of experience in the pharmaceutical industry, Chantale Julien is currently a Global Product Manager at Novo Nordisk Pharmatech A/S, where she manages a portfolio of antimicrobials, specifically benzalkonium chloride products.

Her role encompasses providing technical and scientific support, adherence to Good Distribution Practices (GDP) and strategic market positioning. Mrs. Julien has a deep expertise in pharmaceutical-grade benzalkonium chloride and has successfully led the transformation of product portfolios to meet the evolving demands of the pharmaceutical sector.

Throughout her career, she has held positions at the Canadian Food Inspection Agency, Novonesis (previously Chr. Hansen A/S) and Cook Medical, in various management roles that emphasize compliance, life-cycle product management and API distribution.

Mrs. Julien earned her Master’s degree in Animal Sciences from Université Laval in Québec, Canada.

Message Presenter